Clinical research company Atlanta Center for Medical Research (ACMR) revealed on Tuesday the appointment of Eric Riesenberg (CPA) as its chief executive officer.
Effective immediately, Riesenberg succeeds his father and the company's founder, Dr Robert Riesenberg.
Prior to the new appointment, Riesenberg has served as an advisor to ACMR's board of directors since 2001 and director of operations since 2008.
Currently, Riesenberg is a member of the board of advisors to the Metro Atlanta Chamber of Commerce and works with the Bioscience Leadership Council; a member of the American Israel Chamber of Commerce and works with the medical committee; as well as a member of the Drug Information Association (DIA) and American Society of Clinical Psychopharmacology (ASCP).
GSK releases decade-long data on Shingrix efficacy
GSK announces positive EAGLE-1 results for gepotidacin in gonorrhoea treatment
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline
Charles River Laboratories launches AMAP to reduce animal testing reliance
PureTech completes enrollment in Phase 2b ELEVATE IPF trial for LYT-100
Cybin secures additional US patent for CYB003 breakthrough therapy programme
UroGen's UGN-103 IND accepted by FDA for bladder cancer treatment
Biophytis reinforces obesity IP with new patent application
MaaT Pharma reveals positive 18-month data for MaaT013 in GI-aGvHD
Fusion Antibodies plc secures contract for OptiPhage library development
Innate Pharma advances Sanofi-developed NK cell engager to Phase 2 for blood cancer patients